申请人:HOFFMANN LA ROCHE
公开号:WO2012007365A1
公开(公告)日:2012-01-19
This invention relates to novel 1-hydroxyimino-3-phenyl-propanes of the formula (I) wherein R1 to R10 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and may be used as medicaments for the treatment of diseases such as type II diabetes.
这项发明涉及式(I)中的新型1-羟基亚胺基-3-苯基丙烷,其中R1至R10如描述和权利要求书中所定义,并且其药学上可接受的盐。这些化合物是GPBAR1激动剂,可用作治疗疾病如2型糖尿病的药物。